Establishment of a basis for supporting the production and seller of medical devices for rare diseases

The basis for support has been established for those who produce and sell medical devices and patient special foods used to diagnose and treat rare diseases.

Until now, support for the diagnosis and treatment of rare diseases has been limited to drug producers and sellers, but the scope of support has expanded as the "Rare Disease Control Act amendment" passed the National Assembly.

Ji Young-mi, the head of the Korea Centers for Disease Control and Prevention, said she expects the revision of the legislation to reduce the economic burden on rare patients and their families.